Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 7/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26748242 | 0.90 | KMT2A (0.59) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL29169689 | 0.81 | ALOX15 (0.52) | TSHRALOX15ALDH1A1KMT2AKDM4E | |
| SCHEMBL15372492 | 0.80 | BTN3A1 (0.39) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL16611065 | 0.77 | KDM1A (0.33) | ALOX15ALDH1A1KMT2A | |
| SCHEMBL16611063 | 0.77 | KDM1A (0.33) | ALOX15ALDH1A1KMT2A | |
| Beta-Citronellene SCHEMBL21872 | 0.76 | ALOX15 (0.50) | TSHRALOX15ALDH1A1KMT2A | |
| Beta-Citronellene SCHEMBL2456981 | 0.76 | ALOX15 (0.50) | TSHRALOX15ALDH1A1KMT2A | |
| Beta-Citronellene SCHEMBL7808244 | 0.76 | ALOX15 (0.50) | TSHRALOX15ALDH1A1KMT2A | |
| SCHEMBL29120332 | 0.75 | — | — | |
| SCHEMBL30999495 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150087723-A1 | MICROBIAL COMPOSITION | ROHM AND HAAS COMPANY (US) | 2015-03-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087723-A1 | MICROBIAL COMPOSITION | CD14, MYD88, TLR4 | TSHR 4210/4885ALOX15 291/4885ALDH1A1 427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.